G1 Therapeutics (GTHX) Insider Trading & Ownership → The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (From Smallcaps Daily) (Ad) Free GTHX Stock Alerts $4.69 +0.04 (+0.86%) (As of 05/15/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability G1 Therapeutics (NASDAQ:GTHX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.23%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$397,880.45 Get GTHX Insider Trade Alerts Want to know when executives and insiders are buying or selling G1 Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address GTHX Insider Buying and Selling by Quarter Ad Crypto 101 MediaA ‘DeFi Summer’ Projected!Top analysts are predicting DeFi coins to see massive gains in the coming months… During this dubbed ‘DeFi Summer…’ A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x!Just click here to learn how you can access this coin right now. G1 Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/18/2024John W V UmsteadCFOSell6,547$3.02$19,771.94 2/12/2024Rajesh MalikInsiderSell28,600$4.62$132,132.00 1/4/2024John W V UmsteadCFOSell111$2.94$326.34 1/4/2024Terry L MurdockCOOSell721$2.94$2,119.74 1/3/2024Rajesh MalikInsiderSell3,019$3.12$9,419.28 1/2/2024John E (Jack) Jr. BaileyCEOSell32,983$3.27$107,854.41 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 12/11/2023Rajesh MalikInsiderSell33,839$3.41$115,390.99 7/5/2023Andrew PerryInsiderSell355$2.45$869.75 7/5/2023John E (Jack) Jr. BaileyCEOSell2,719$2.45$6,661.55 7/5/2023Terry L MurdockCOOSell1,361$2.45$3,334.45 (Data available from 1/1/2013 forward) GTHX Insider Trading Activity - Frequently Asked Questions Who is on G1 Therapeutics's Insider Roster? The list of insiders at G1 Therapeutics includes Andrew Perry, James S Hanson, Jennifer K Moses, John E (Jack) Jr. Bailey, John W V Umstead, Mark A Velleca, Rajesh Malik, and Terry L Murdock. Learn more on insiders at GTHX. What percentage of G1 Therapeutics stock is owned by insiders? 8.23% of G1 Therapeutics stock is owned by insiders. Learn more on GTHX's insider holdings. Which G1 Therapeutics insiders have been selling company stock? The following insiders have sold GTHX shares in the last 24 months: Andrew Perry ($5,445.35), Jennifer K Moses ($9,145.62), John E (Jack) Jr. Bailey ($301,827.11), John W V Umstead ($20,098.28), Mark A Velleca ($1,456,700.00), Rajesh Malik ($539,722.27), and Terry L Murdock ($12,748.24). How much insider selling is happening at G1 Therapeutics? Insiders have sold a total of 279,110 G1 Therapeutics shares in the last 24 months for a total of $2,345,686.87 sold. More Insider Trading Tools from MarketBeat Related Companies: Zevra Therapeutics Insider Ownership Merrimack Pharmaceuticals Insider Ownership Puma Biotechnology Insider Ownership uniQure Insider Ownership Emergent BioSolutions Insider Ownership Atossa Therapeutics Insider Ownership Ovid Therapeutics Insider Ownership Generation Bio Insider Ownership Omeros Insider Ownership Rigel Pharmaceuticals Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are Buying This page (NASDAQ:GTHX) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding G1 Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.